Adverse events: hypotension · idiopathic steroid‐resistant nephrotic syndrome in children
It is very uncertain whether rituximab/cyclosporin/prednisolone changes adverse events: hypotension compared with cyclosporin/prednisolone (very low certainty).
1 finding from 1 review
Adverse effects of antibiotics (skin rash) · idiopathic steroid‐resistant nephrotic syndrome in children
It is very uncertain whether rituximab/cyclosporin/prednisolone changes adverse events: skin rash compared with cyclosporin/prednisolone (very low certainty).
1 finding from 1 review
Adverse events: mild dyspnoea · idiopathic steroid‐resistant nephrotic syndrome in children
It is very uncertain whether rituximab/cyclosporin/prednisolone changes adverse events: mild dyspnoea compared with cyclosporin/prednisolone (very low certainty).
1 finding from 1 review
Taking adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in taking adherence compared with standard care (low certainty).
1 finding from 1 review
Dosing adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence may leads to higher dosing adherence compared with standard care (low certainty).
1 finding from 1 review
Timing adherence · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in timing adherence compared with standard care (low certainty).
1 finding from 1 review
Drug holidays · solid organ transplant recipients
Interventions for increasing immunosuppressant medication adherence showed no clear difference in drug holidays compared with standard care (low certainty).
1 finding from 1 review
Adherence · solid organ transplant recipients
It is very uncertain whether interventions for increasing immunosuppressant medication adherence changes self‐reported adherence (proportion) compared with standard care (very low certainty).
2 findings from 1 review
Systolic blood pressure · patients with diabetes with or without CKD
1 finding from 1 review
Diastolic blood pressure · patients with diabetes with or without CKD
1 finding from 1 review
MAP Duration: up to 12 weeks · patients with diabetes with or without CKD
1 finding from 1 review
Systolic blood pressure · patients with diabetes with or without CKD
3 findings from 1 review
no estimate extracted
7 studies · 288 participants
Low
no estimate extracted
5 studies · 112 participants
Low
no estimate extracted
5 studies · 108 participants
Low
MAP Duration: up to 12 weeks · patients with diabetes with or without CKD
2 findings from 1 review
Diastolic blood pressure · patients with diabetes with or without CKD
3 findings from 1 review
no estimate extracted
7 studies · 288 participants
Low
no estimate extracted
5 studies · 112 participants
Low
no estimate extracted
5 studies · 108 participants
Low
Fatigue · people receiving dialysis
1 finding from 1 review
Weakness · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Energy · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tiredness · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Exhaustion · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Asthenia · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found